Big data and predictive modelling for the opioid crisis: existing research and future potential.


Journal

The Lancet. Digital health
ISSN: 2589-7500
Titre abrégé: Lancet Digit Health
Pays: England
ID NLM: 101751302

Informations de publication

Date de publication:
06 2021
Historique:
received: 24 11 2020
revised: 21 01 2021
accepted: 24 03 2021
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 29 6 2021
Statut: ppublish

Résumé

A need exists to accurately estimate overdose risk and improve understanding of how to deliver treatments and interventions in people with opioid use disorder in a way that reduces such risk. We consider opportunities for predictive analytics and routinely collected administrative data to evaluate how overdose could be reduced among people with opioid use disorder. Specifically, we summarise global trends in opioid use and overdoses; describe the use of big data in research into opioid overdose; consider the potential for predictive modelling, including machine learning, for prevention and monitoring of opioid overdoses; and outline the challenges and risks relating to the use of big data and machine learning in reducing harms that are related to opioid use. Future research for improving the coverage and provision of existing interventions, treatments, and resources for opioid use disorder requires collaboration of multiple agencies. Predictive modelling could transport the concept of stratified medicine to public health through novel methods, such as predictive modelling and emulated trials for evaluating diagnoses and prognoses of opioid use disorder, predicting treatment response, and providing targeted treatment recommendations.

Identifiants

pubmed: 34045004
pii: S2589-7500(21)00058-3
doi: 10.1016/S2589-7500(21)00058-3
pii:
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e397-e407

Subventions

Organisme : Medical Research Council
ID : MR/N00616X/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests LD has received untied educational funding from Reckitt Benckiser, Indivior, Mundipharma, and Seqirus, outside the submitted work. All other authors declare no competing interests.

Auteurs

Chrianna Bharat (C)

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia. Electronic address: c.bharat@student.unsw.edu.au.

Matthew Hickman (M)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Sebastiano Barbieri (S)

Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW, Australia.

Louisa Degenhardt (L)

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH